Veradigm Partners With CareMetx, LLC To Optimize End-To-End Specialty Medication Access And Services Streamlining Patient Care
New Strategic Partnership Will Simplify and Accelerate Specialty Approval Medication Process
Veradigm, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions, and CareMetx, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced today a new agreement for CareMetx to integrate its solutions and services directly into the Veradigm AccelRx® specialty medication platform.
Recommended AI News: EdgeCortix Acquires Multiple Patents for Dynamic Neural Accelerator AI Processor Technology
The agreement will make Veradigm’s AccelRx automated solutions for specialty medication enrollment, among others, available directly to CareMetx clients. Empowering users of Veradigm and Allscripts® electronic health records to access CareMetx specialty medication patient access hub services via AccelRx. This combination strengthens the ability to reduce time to therapy for patients, thereby driving higher adherence to their prescribed care plan, while also minimizing administrative burden on medical practices.
To receive their specialty medication, a patient’s prescription must pass through a broad cross-section of healthcare industry stakeholders, from biopharma companies and payers, to specialty pharmacies and specialty medication hubs. A 2020 survey of prescribers, from Veradigm, found that 9 out of 10 physicians said patient medication adherence would improve if specialty medication prescriptions could be filled more easily and delivered to patients quicker, while 8 in 10 said accessing multiple specialty medication portals/hubs has a negative effect on their practice.1
“Veradigm is committed to transforming health insightfully for healthcare professionals managing the specialty medication approval process, and most importantly to better support their patients,” said Tom Langan, CEO of Veradigm. “This new agreement with CareMetx is our latest step toward that end. By working with hub services leaders like CareMetx, we can continue to drive improvement in the specialty medication fulfillment process and decrease patient wait times, enabling them to begin their prescribed therapies sooner. Reducing time-to-therapy, for these already complex medications in turn, can contribute to increased medication adherence and in the end better outcomes.”
Recommended AI News: HiDubai Introduces a New AI-Powered Deal Discovery Feature to Help Tourists and Residents Do Smart Shopping
Serving pharmaceutical, biotechnology and device manufacturers, CareMetx leverages a digital hub platform to provide efficient delivery of eServices. CareMetx leadership in patient access promotes efficiency in the healthcare ecosystem, removing barriers for patients and providers alike.
“The faster and more seamless the flow of secure healthcare data between leading specialty medication hubs like CareMetx and electronic health records, the better we can both serve patients and providers in simplifying the often-challenging process of fulfilling specialty medication prescriptions,” said Mark Hansan, Chief Executive Officer of CareMetx. “The scope and reach of Veradigm’s provider network offers opportunities to initiate essential patient support services and risk evaluation, all without the EHR user having to leave their workflow.”
Recommended AI News: Qventus Introduces New Perioperative Solution to Increase Prime Time Utilization and Grow Case Volume
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.